Sponsor

Elevar Therapeutics Inc.

United States 1 Bridge Plaza North Suite 850, 07024-7101, United States

About the sponsor

Elevar Therapeutics Inc. focuses its clinical research on cholangiocarcinoma, including intrahepatic cholangiocarcinoma, alongside other advanced solid tumors. The sponsor’s active program reflects interest in difficult-to-treat hepatobiliary cancers and broader oncology settings where targeted treatment options are needed.

Intrahepatic cholangiocarcinoma
Advanced solid tumors
Hepatobiliary malignancies

The research portfolio centers on cancer therapeutics for patients with limited treatment choices, with attention to tumor control and clinical benefit in advanced malignancy.

About Specializations

Elevar Therapeutics Inc. runs clinical trials in conditions such as Neoplasm, Endometrial cancer, Gastric cancer, Hepatocellular carcinoma, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

2 clinical trials

Endometrial cancer+6

Not yet recruiting

Phase 2 Study of Lirafugratinib in Patients with Previously Treated Unresectable Advanced Solid Tumors with FGFR2 Fusion (Excluding Cholangiocarcinoma)

InvestigationalNo placebo